Summary
Immunohistochemical analysis for products of vasopressin and oxytocin gene expression was performed on acetone-fixed tissues from 19 breast cancers representing a variety of tumor sub-types. Studies employed the avidin-biotin complex (ABC) immunohistochemical procedure and utilized rabbit polyclonal antibodies to arginine vasopressin (VP), provasopressin (ProVP), vasopressin-associated human glycopeptide (VAG), oxytocin (OT), oxytocin-associated human neurophysin (OT-HNP), and a mouse monoclonal antibody to vasopressin-associated human neurophysin (VP-HNP). Western Blot analysis was performed on protein extracts of fresh-frozen tissues from 12 additional breast tumors. While VP gene related proteins were not detected in normal breast tissue, immunohistochemistry revealed the presence of VP, Pro VP, and VAG in all neoplastic cells for all of the tumor tissues examined. Vasopressin-associated human neurophysin was evident in only one of 19 acetone-fixed tumor preparations. However, Western blot analysis for all 12 fresh-frozen tumor samples showed the presence of two proteins, 42,000 and 20,000 daltons, that were immunoreactive with antibodies to VP, VP-HNP, and VAG. Oxytocin and OT-HNP, by immunohistochemistry, were found to be common to cells of normal breast tissues. For tumors, positive staining for OT was observed in 8 of 18 tumors, while OT-HNP was not detected in any of the tumors examined. These findings indicate that VP gene expression is a selective feature of all breast cancers, and that products of this expression might therefore be useful as markers for early detection of this disease and as possible targets for immunotherapy.
References
Colditz GA: Epidemiology of breast cancer. Cancer 71: 1480–1489, 1993
Strax P: Detection of breast cancer. Cancer 66: 1336–1340, 1990
Lippman ME: The development of biological therapies for breast cancer. Science 259: 631–632, 1993
Kellen JA, Wong A, Georges E, Ling V: R-verapamil decreases anti-estrogen resistance in a breast cancer model. Anticancer Research 11: 809–812, 1991
North WG: Neuropeptide production by small cell carcinoma: vasopressin and oxytocin as plasma markers of disease. J Clin Endocrinol Metab 73: 1316–1320, 1991
Friedmann AS, Malott KA, Memoli VA, Pai SI, Yu XM, North WG: Products of vasopressin gene expression in small-cell carcinoma of the lung. Br J Cancer 69: 260–263, 1993
North WG, Maurer LH, Valtin H, O'Donnell J: Human neurophysins as potential tumor markers for small cell carcinoma of the lung: application of specific radioimmunoassays. J Clin Endocrinol Metab 51: 892–896, 1980
North WG, Yu X-M: Vasopressin mRNA and neurophysin-related cell-surface antigen (NRSA) of small-cell carcinoma. Peptides 14: 303–307, 1993
North WG, Hirsh V, Lisbona R, Schulz J, Cooper B: Imaging of small cell carcinoma using 131I-labelled antibodies to vasopressin associated human neurophysin (VP-HNP). Nuclear Med Comm 10: 643–651, 1989
Taylor AH, Ang VTY, Jenkins JS, Silverlight JJ, Coombes RC, Luqmani YA: Interaction of vasopressin and oxytocin with human breast cancer cells. Cancer Res 50: 7882–7886, 1990
Robbins SL, Kumar V: Basic Pathology. W B Saunders Co, Philadelphia, 1987, pp 657–670
Sato Y, Mukai K, Watanabe S, Goto M, Shimosato Y: The AMeX Method. A J Pathol 125: 431–435, 1986
North WG, LaRochelle FT Jr, Melton J, Mills R: Isolation and partial characterization of two human neurophysins: Their use in the development of specific radioimmunoassays. J Clin Endocrinol Metab 51: 884–891, 1980
Rosenbaum L, Neuwelt E, Van Tol H, Loh P, Verbalis J, Hellstrom I, Hellstrom K, Nilaver G: Expression of neurophysin-related precursor in cell membranes of small-cell carcinoma. Proc Natl Acad Sci 87: 9928–9932, 1990
Streefkerk JG: Erythrocyte pseudoperoxidase activity by treatment with hydrogen peroxide following methanol. J Histochem Cytochem 20: 829–831, 1972
Laemeli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685, 1970
Sethi T, Langdon S, Smyth J, Rozengurt E: Growth of small cell lung cancer cells: Stimulation by multiple neuropeptides and inhibition by broad spectrum antagonistsin vitro andin vivo. Cancer Res 52: 2737s-2742s, 1992
Monaco ME, Kidwell WR, Lippman ME: Neurohypophy-sial-hormone-responsive cell line derived from a dimethylbenzanthracene-induced rat mammary tumour. Biochem J 188: 437–441, 1980
North WG, Friedmann AS, Yu X-M: Tumor biosynthesis of vasopressin and oxytocin. In: North WG, Moses A, Share L (eds) The Neurohypophysis: A Window on Brain Function. Ann NY Acad Sci, New York, 1993, pp 107–121
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
North, W.G., Pai, S., Friedmann, A. et al. Vasopressin gene related products are markers of human breast cancer. Breast Cancer Res Tr 34, 229–235 (1995). https://doi.org/10.1007/BF00689714
Issue Date:
DOI: https://doi.org/10.1007/BF00689714